Standout Papers

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer 2013 2026 2017 2021 1.6k
  1. Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer (2013)
    Sarah‐Jane Dawson, Dana W.Y. Tsui et al. New England Journal of Medicine

Citation Impact

Citing Papers

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
2016
Trans-splicing of the C. elegans let-7 primary transcript developmentally regulates let-7 microRNA biogenesis and let-7 family microRNA activity
2019 StandoutNobel
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials
2015
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
2016
Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
2014
The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
2016
Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma
2016
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 Standout
Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology
2015
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors
2016
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
2019 Standout
Diagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis
2021 Standout
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients
2016
Cell-free circulating tumor DNA in cancer
2016
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study
2020
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
2015
Mammographic Density and the Risk and Detection of Breast Cancer
2007 Standout
Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection
2018
A view on drug resistance in cancer
2019 StandoutNature
Liquid biopsy: monitoring cancer-genetics in the blood
2013
Biologic Characteristics of Interval and Screen-Detected Breast Cancers
2000
Mass detection in digital breast tomosynthesis: Deep convolutional neural network with transfer learning from mammography
2016
Using deep convolutional neural networks to identify and classify tumor-associated stroma in diagnostic breast biopsies
2018
No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis
2018
Capture and Amplification by Tailing and Switching (CATS)
2014
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Computer-Aided Diagnosis and Artificial Intelligence in Clinical Imaging
2011
Recent advances in diffuse optical imaging
2005
Mammographic Screening and “Overdiagnosis”
2011
Integrating liquid biopsies into the management of cancer
2017
Circulating tumour cells and cell-free DNA as tools for managing breast cancer
2013
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Fragment Length of Circulating Tumor DNA
2016
AI in health and medicine
2022 Standout
Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer
2016
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
Advances in the treatment of advanced oestrogen-receptor-positive breast cancer
2016
Nasopharyngeal carcinoma
2019 Standout
Cancer stem cells revisited
2017 Standout
Large language models in medicine
2023 Standout
A comparison of the accuracy of film-screen mammography, full-field digital mammography, and digital breast tomosynthesis
2012
Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer
2014
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
2016
Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting
2010
Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study
2016
Non-invasive imaging through opaque scattering layers
2012 StandoutNature
Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study
2013 Standout
Tumor metastasis: moving new biological insights into the clinic
2013
Lung cancer: current therapies and new targeted treatments
2016 Standout
Machine Learning and Prediction in Medicine — Beyond the Peak of Inflated Expectations
2017 Standout
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer
2014
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
2016
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
2015
A survey on deep learning in medical image analysis
2017 Standout
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
2015
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Overview of the evidence on digital breast tomosynthesis in breast cancer detection
2013
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
2018
Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
2017
Emerging Biological Principles of Metastasis
2017 Standout
The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality
2012
The diagnostic accuracy of dual-view digital mammography, single-view breast tomosynthesis and a dual-view combination of breast tomosynthesis and digital mammography in a free-response observer performance study
2010
EMT: 2016
2016 Standout
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
2014
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Integrated digital error suppression for improved detection of circulating tumor DNA
2016
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients
2016
PyClone: statistical inference of clonal population structure in cancer
2014
The evolving role of new imaging methods in breast screening
2011
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study
2016
The PI3K Pathway in Human Disease
2017 Standout
Origins, structures, and functions of circulating DNA in oncology
2016
Artificial intelligence in radiology
2018 Standout
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
2014
Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
2005 Standout
Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening Program
2013 Standout
Hepatocellular carcinoma
2022 Standout
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
2016
Estrogen-Plus-Progestin Use and Mammographic Density in Postmenopausal Women: Women's Health Initiative Randomized Trial
2005
Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
2014
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
2015
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
2015
Cancer biomarkers: Written in blood
2014 Nature
Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor‐sensitizing and resistance mutations in the plasma DNA of patients with advanced non–small cell lung cancer during treatment with erlotinib
2014
Hepatocellular Carcinoma
2019 Standout
Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection
2015
Discriminating solitary cysts from soft tissue lesions in mammography using a pretrained deep convolutional neural network
2017
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
2015
Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay
2016
Comparing the performance of mammography screening in the USA and the UK
2005
Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer
2016
Tumor clone dynamics in lethal prostate cancer
2014
Predicting the Future — Big Data, Machine Learning, and Clinical Medicine
2016 Standout
Breast Cancer Treatment
2019 Standout
Implementing Machine Learning in Health Care — Addressing Ethical Challenges
2018 Standout
Case–Control and Two-Gate Designs in Diagnostic Accuracy Studies
2005
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
2016
Beyond prediction: Using big data for policy problems
2017 StandoutScience
Detection of soft tissue densities from digital breast tomosynthesis: comparison of conventional and deep learning approaches
2016
Wound Healing: A Cellular Perspective
2018 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Noninvasive monitoring of infection and rejection after lung transplantation
2015
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
2015
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
2015
Impact of Computer-Aided Detection Systems on Radiologist Accuracy With Digital Mammography
2014
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
2014
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Global cancer statistics, 2012
2015 Standout
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
2014
A machine learning approach for somatic mutation discovery
2018
Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography
2014 Standout

Works of Matthew Wallis being referenced

The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS
2012
Characterization of Cystic Lesions by Spectral Mammography
2016
Mass detection in reconstructed digital breast tomosynthesis volumes with a computer‐aided detection system trained on 2D mammograms
2013
The Royal College of Radiologists Breast Group breast imaging classification
2009
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Two-View and Single-View Tomosynthesis versus Full-Field Digital Mammography: High-Resolution X-Ray Imaging Observer Study
2012
Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival
2008
Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study
2004
Classifying interval cancers
1995
Mammographic Features of Breast Cancers at Single Reading with Computer-aided Detection and at Double Reading in a Large Multicenter Prospective Trial of Computer-aided Detection: CADET II
2010
Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the million women study
2004
Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias
2008
Single Reading with Computer-Aided Detection for Screening Mammography
2008
Does individual programme size affect screening performance? Results from the United Kingdom NHS breast screening programme
2002
Screening histories of invasive breast cancers diagnosed 1989–2006 in the West Midlands, UK: variation with time and impact on 10-year survival
2009
Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists
2018
The effect of digitising film prior mammograms on radiologists' performance in breast screening: a JAFROC study
2009
Rankless by CCL
2026